MARKER THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
MARKER THERAPEUTICS, INC. (MRKR) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of $4.51 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-26.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2024-03-26
- MARKER THERAPEUTICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2023 was $4.51M, a 342.79% increase from fiscal 2022.
- MARKER THERAPEUTICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2022 was $1.02M, a 889.32% increase from fiscal 2021.
- MARKER THERAPEUTICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2021 was $103.00K, a 56.54% decline from fiscal 2020.
- MARKER THERAPEUTICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2020 was $237.00K.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month as first filed |
|---|---|---|
| 2023-12-31 | $4.51M 10-K · filed 2024-03-26 | |
| 2022-12-31 | $1.02M 10-K · filed 2024-03-26 | |
| 2021-12-31 | $103.00K 10-K · filed 2023-03-22 | |
| 2020-12-31 | $237.00K 10-K · filed 2022-03-17 | |
| 2019-12-31 | -$274.00K 10-K · filed 2021-03-09 | |
| 2018-12-31 | $0.00 10-K · filed 2019-03-15 | |
| 2017-12-31 | -$48.00K 10-K · filed 2019-03-15 | $20.00K 10-K · filed 2018-03-23 |
| 2016-12-31 | $128.00K 10-K · filed 2018-03-23 | |
| 2015-12-31 | $346.00K 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |